Hideaki Tahara

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 13

Top Venues

Cancer science

Molecular cancer research : MCR

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Yu Mizote, Takako Inoue, Takashi Akazawa, Kei Kunimasa, Motohiro Tamiya, Yachiyo Kumamoto, Arisa Tsuda, Satomi Yoshida, Kumiko Tatsumi, Tomoya Ekawa, Keiichiro Honma, Kazumi Nishino, Hideaki Tahara
Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG-E8. Cancer science 115 (4) (2024)
Sisca Ucche, Satoru Yokoyama, Marija Mojic, Kohei Oki, Chikako Ohshima, Haruka Tsuihiji, Ichiro Takasaki, Hideaki Tahara, Yoshihiro Hayakawa
GSTA4 governs melanoma immune resistance and metastasis. Molecular cancer research : MCR (2022)
Makoto Fujimoto, Miki Kamiyama, Kosuke Fuse, Hiroki Ryuno, Takeru Odawara, Natsuki Furukawa, Yasuhiro Yoshimatsu, Tetsuro Watabe, Michaela Prchal-Murphy, Veronika Sexl, Hideaki Tahara, Yoshihiro Hayakawa, Takehiro Sato, Kohsuke Takeda, Isao Naguro, Hidenori Ichijo
ASK1 suppresses NK cell-mediated intravascular tumor cell clearance in lung metastasis. Cancer science 112 (4) (2021)
Marija Mojic, Kiyomi Shitaoka, Chikako Ohshima, Sisca Ucche, Fulian Lyu, Hiroshi Hamana, Hideaki Tahara, Hiroyuki Kishi, Yoshihiro Hayakawa
NKG2D defines tumor-reacting effector CD8+ T cells within tumor microenvironment. Cancer science 112 (9) (2021)
Kiho Miyazato, Hideaki Tahara, Yoshihiro Hayakawa
Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells. Cancer science 111 (8) (2020)
Takashi Kanemura, Hiroshi Miyata, Tomoki Makino, Koji Tanaka, Keijiro Sugimura, Mika Hamada-Uematsu, Yu Mizote, Hiroaki Uchida, Yasuhiro Miyazaki, Tsuyoshi Takahashi, Yukinori Kurokawa, Makoto Yamasaki, Hisashi Wada, Kiyokazu Nakajima, Shuji Takiguchi, Masaki Mori, Yuichiro Doki, Hideaki Tahara
Immunoregulatory influence of abundant MFG-E8 expression by esophageal cancer treated with chemotherapy. Cancer science 109 (11) (2018)
Yutaka Yamamoto, Kiho Miyazato, Kei Takahashi, Naoki Yoshimura, Hideaki Tahara, Yoshihiro Hayakawa
Lung-resident natural killer cells control pulmonary tumor growth in mice. Cancer science 109 (9) (2018)
Naoya Yamazaki, Yoshio Kiyohara, Hisashi Uhara, Hajime Iizuka, Jiro Uehara, Fujio Otsuka, Yasuhiro Fujisawa, Tatsuya Takenouchi, Taiki Isei, Keiji Iwatsuki, Hiroshi Uchi, Hironobu Ihn, Hironobu Minami, Hideaki Tahara
Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma. Cancer science 108 (5) (2017)

Hideaki Tahara.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hideaki Tahara